# Rani Therapeutics Holdings, Inc.: Form 8-K, filed May 29, 2026

- Company: [Rani Therapeutics Holdings, Inc.](/companies/rani.md) (CIK 1856725)
- Form: 8-K
- Filed: 2026-05-29
- Accepted by EDGAR: May 28, 2026, 18:12 ET
- Period: 2026-05-28
- Accession: 0001193125-26-245636
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/rani-20260528.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/rani-20260528.htm

Filed May 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-245636. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.
